Roth Mkm downgraded shares of CareCloud (NASDAQ:CCLD – Free Report) from a buy rating to a neutral rating in a research report report published on Wednesday, MarketBeat reports. They currently have $3.50 target price on the stock, down from their prior target price of $5.00.
Separately, Benchmark boosted their price objective on CareCloud from $4.00 to $4.50 and gave the stock a “buy” rating in a research note on Tuesday, August 27th.
CareCloud Stock Down 3.5 %
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the stock. Renaissance Technologies LLC increased its stake in shares of CareCloud by 25.1% during the second quarter. Renaissance Technologies LLC now owns 107,200 shares of the company’s stock worth $206,000 after purchasing an additional 21,500 shares during the period. Heron Bay Capital Management increased its stake in CareCloud by 126.8% during the 2nd quarter. Heron Bay Capital Management now owns 34,576 shares of the company’s stock worth $66,000 after acquiring an additional 19,329 shares during the period. Finally, XTX Topco Ltd acquired a new position in shares of CareCloud during the 3rd quarter worth $42,000. 10.16% of the stock is owned by institutional investors and hedge funds.
CareCloud Company Profile
CareCloud, Inc, a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services.
See Also
- Five stocks we like better than CareCloud
- Using the MarketBeat Dividend Yield Calculator
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- 3 Fintech Stocks With Good 2021 Prospects
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Time to Load Up on Home Builders?
Receive News & Ratings for CareCloud Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareCloud and related companies with MarketBeat.com's FREE daily email newsletter.